The origin remained unknown, and health officials were racing to find it
Em meados de abril de 2022, autoridades sanitárias de vários países europeus e dos Estados Unidos se viram diante de um enigma que resistia a explicações convencionais: uma onda de hepatite aguda em crianças, sem agente causador identificado e sem rota clara de prevenção. O Reino Unido havia registrado 74 casos até 8 de abril, e o surto se espalhava para Irlanda, Países Baixos, Dinamarca, Espanha e além do Atlântico — enquanto os cinco vírus hepatíticos conhecidos já haviam sido descartados como responsáveis. Seis crianças precisaram de transplante de fígado, lembrando ao mundo que o desconhecido, quando afeta os mais jovens, exige tanto urgência quanto humildade científica.
- Um surto de hepatite aguda em crianças de até 16 anos avança por múltiplos países sem que nenhum vírus hepatítico conhecido tenha sido identificado como causa.
- Seis crianças já necessitaram de transplante de fígado, e outras foram internadas em unidades pediátricas especializadas, revelando a gravidade clínica do que ainda permanece sem nome.
- Adenovírus e SARS-CoV-2 foram detectados em alguns pacientes, mas nenhum dos dois pôde ser apontado como culpado definitivo — a investigação avança sem certezas.
- A OMS orienta países a identificar, investigar e notificar casos suspeitos, enquanto recomenda higiene básica como única medida preventiva disponível no momento.
- Sem mortes registradas até 11 de abril e sem restrições de viagem recomendadas, a situação permanece sob monitoramento tenso — mais confirmações são esperadas antes que qualquer resposta conclusiva chegue.
Em meados de abril de 2022, autoridades de saúde europeias enfrentavam um surto de hepatite aguda em crianças que desafiava o diagnóstico convencional. O Reino Unido havia documentado 74 casos até 8 de abril, e o fenômeno já se espalhava para Irlanda, Países Baixos, Dinamarca, Espanha e Estados Unidos. O elemento mais perturbador não era apenas a dispersão geográfica, mas a ausência de uma causa identificável: todos os cinco vírus hepatíticos conhecidos — de A a E — haviam sido descartados pelos exames laboratoriais.
A hepatite é, em essência, uma inflamação do fígado que pode evoluir para complicações graves como cirrose e falência orgânica. No cenário global, os tipos B e C são os mais letais, afetando cronicamente cerca de 354 milhões de pessoas. Mas este surto seguia uma lógica diferente. As crianças afetadas, em sua maioria entre 2 e 5 anos, apresentavam sintomas clássicos — urina escura, icterícia, fadiga, dor abdominal — e alguns casos eram graves o suficiente para exigir internação em unidades pediátricas especializadas. Seis delas precisaram de transplante de fígado. Nenhuma morte havia sido registrada até 11 de abril.
As investigações britânicas, em curso desde janeiro, identificaram a presença de adenovírus e SARS-CoV-2 em parte dos pacientes, mas sem conseguir estabelecer nexo causal. Nenhum fator de risco epidemiológico comum emergiu — sem viagens internacionais recentes, sem exposição compartilhada. As autoridades do Reino Unido descartaram explicitamente qualquer relação com a vacinação contra a COVID-19.
A OMS reconheceu a tendência crescente e antecipou mais confirmações antes que uma causa fosse identificada. Sem recomendar restrições de viagem, a organização pediu que todos os países membros monitorassem e notificassem casos suspeitos. Meera Chand, diretora de infecções clínicas e doenças emergentes do Reino Unido, orientou pais e responsáveis a reforçar a higiene das mãos e a buscar atendimento médico imediato diante de qualquer sintoma hepático. Enquanto a investigação avançava sem respostas definitivas, crianças em múltiplos países permaneciam hospitalizadas — e o mundo aguardava.
By mid-April 2022, health authorities across Europe were confronting a puzzle that defied easy answers: a wave of acute hepatitis in children, with no clear culprit and no obvious path to prevention. The United Kingdom had documented 74 cases by April 8, according to the World Health Organization. From there, the outbreak rippled outward—to Ireland, the Netherlands, Denmark, Spain, and across the Atlantic to the United States. What made it alarming was not just the spread, but the mystery at its core. Standard laboratory tests had ruled out the five known hepatitis viruses that typically cause such illness in children. The origin remained unknown, and health officials were racing to find it.
Hepatitis itself is straightforward enough to describe: an inflammation of the liver triggered by infectious viruses or non-infectious agents. The disease can spiral into serious complications—cirrhosis, liver cancer, organ failure. Five distinct viral strains exist, labeled A through E, each with different transmission routes, geographic patterns, and severity profiles. Hepatitis B and C are the heavyweights in the global disease burden, causing chronic infection in an estimated 354 million people worldwide and driving most hepatitis-related deaths and liver cancers. But this outbreak in children was different. The traditional suspects had been eliminated.
Investigators in the UK had been studying these cases since January, methodically collecting data and running tests. What they found was tantalizing but inconclusive. Some children showed evidence of adenovirus infection—a common family of viruses that typically causes mild illness. Others tested positive for SARS-CoV-2, the coronavirus behind COVID-19. Both viruses were circulating in the region at elevated levels. Yet neither could be definitively pinned as the cause. The role these viruses played in actually triggering the hepatitis remained unclear. No other epidemiological risk factors emerged—no recent international travel, no common exposure. The UK health authorities explicitly ruled out any link to COVID-19 vaccination; none of the confirmed cases had received a vaccine.
The children affected ranged up to age 16, though most cases clustered between ages 2 and 5. They presented with the classic signs of acute liver inflammation: dark urine, pale or grayish stools, itching skin, yellowing of the eyes and skin, muscle and joint pain, fatigue, loss of appetite, and abdominal discomfort. Many experienced gastrointestinal symptoms first, followed by jaundice. The illness was severe enough that some children required transfer to specialized pediatric liver units. Six required liver transplants—a dramatic intervention that underscored the seriousness of what was unfolding. As of April 11, no deaths had been recorded, a small mercy in an otherwise troubling situation.
The geographic distribution told its own story. Within the United Kingdom, 49 cases came from England, 13 from Scotland, with additional cases in Wales and Northern Ireland. But the outbreak was not contained to Britain. After the UK sounded the alarm, other European nations began reporting their own confirmed and suspected cases. Authorities in Ireland, Spain, the Netherlands, and Denmark all notified the WHO. The United States reported cases as well. Each country began implementing the same investigative playbook: reviewing patient exposure histories, running toxicology tests, conducting viral and microbiological screening.
The World Health Organization acknowledged the growing trend and prepared for more confirmations before any cause would be identified. The organization did not recommend restricting travel to affected countries—a deliberate choice to avoid panic while maintaining vigilance. Instead, the WHO encouraged all member nations to identify, investigate, and report potential cases. Meera Chand, the UK health authority's director of clinical infections and emerging diseases, offered parents and guardians practical guidance: conventional hygiene measures—thorough handwashing and respiratory hygiene—could reduce transmission of many of the infections under investigation. She urged caregivers to watch for hepatitis symptoms and contact healthcare providers immediately if they appeared.
As of mid-April, no confirmed cases had been documented outside Europe, though the WHO had alerted all member states to remain vigilant. Brazil, like other nations, was watching and waiting. Health authorities there had not yet reported any cases, and official responses to inquiries about preparedness remained forthcoming. The outbreak remained contained geographically, but the absence of a known cause meant that containment could not be guaranteed. The investigation would continue, cases would likely accumulate, and the search for answers would intensify—all while children in multiple countries remained hospitalized, some facing the prospect of liver transplantation, and parents everywhere wondered what invisible threat their children might encounter.
Notable Quotes
Conventional hygiene measures, such as thorough handwashing and respiratory hygiene, help reduce transmission of many of the infections under investigation.— Meera Chand, UK Health Security Agency director of clinical infections and emerging diseases
The Hearth Conversation Another angle on the story
Why is this outbreak so difficult to pin down? Doctors have been looking since January.
Because the usual suspects don't fit. Every hepatitis virus we know—A through E—tested negative. That's actually the first clue that something different is happening here.
But they found adenovirus and COVID-19 in some of the children. Isn't that the answer?
That's what makes it so frustrating. Yes, those viruses are present in some cases, but presence isn't the same as cause. You can carry a virus without it triggering hepatitis. The mechanism—how it actually damages the liver—remains a mystery.
Six children needed liver transplants. That's severe. Are we looking at something new?
It appears to be. The severity and the pattern—mostly young children, acute onset, no clear epidemiological link—suggests something we haven't encountered before, or at least not in this form.
Should people be afraid to travel to Europe?
The WHO says no, and that's probably right. But it's also honest about uncertainty. They're not restricting travel because they don't want to overreact, but they're monitoring closely because they genuinely don't know what's coming next.
What can parents actually do?
Wash hands, teach respiratory hygiene, watch for symptoms. It's not much, but it's what we know works against most infections. The hard truth is that without knowing the cause, prevention is mostly guesswork.
Will they find the answer?
Almost certainly, eventually. But the WHO expects more cases before they do. That's the difficult part—knowing it will get worse before it gets better.